[1
]
From the Department of Neurology, Kreisklinikum Siegen, Siegen, Germany (M.G.); Department
of Neurology, Hainich Klinikum, Mühlhausen, Germany (M.J.); Department of Neurology,
HSK Klinik, Wiesbaden, Germany (G.H.); Department of Neurology, Klinikum Offenbach,
Offenbach, Germany (E.S.); Department of Neurology, University of Heidelberg, Germany
(R.V.); Department of Neurology, Vivantes Klinikum Neukölln, Berlin, Germany (D.N.);
Department of Neurology, Klinikum Bad Hersfeld, Bad Hersfeld, Germany (M.H.); Department
of Neurology, University of Essen, Germany (C.W.); Department of Neurology, University
of Erlangen, Germany (M.K.); Department of Neurology, University of Göttingen, Germany
(R.W.); Sanofi-Aventis Deutschland, Berlin, Germany (L.R.); and University of Birmingham
Centre for Cardiovascular Sciences, Birmingham, UK, and Department of Cardiovascular
Medicine and Atrial Fibrillation competence NETwork (AFNET), University Hospital Münster,
Germany (P.K.).